{
    "clinical_study": {
        "@rank": "156444", 
        "acronym": "NIVAS", 
        "arm_group": [
            {
                "arm_group_label": "Non invasive ventilation (NIV)", 
                "arm_group_type": "Experimental", 
                "description": "Experimental arm = non invasive ventilation (NIV) which associated pressure support ventilation (PSV: 5 to 15 cmH2O) and positive end expiratory pressure (PEEP: 5 to 10 cmH2O) NIV will intermittently delivered to the patients for at least six hours (cumulative tme of all trials which lasted at least 30 min) during the first 24h after the initiation of treatment.  Between each NIV period, the patient will received supplemental oxygen through facial mask to achieve an oxygen saturation level above 94%."
            }, 
            {
                "arm_group_label": "standard oxygen therapy with facial mask", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients assigned to standard medical therapy will received supplemental oxygen via a facial Venturi mask at a rate of up to 15 liters per minute with in order to maintain peripheral oxygen saturation above 94%."
            }
        ], 
        "brief_summary": {
            "textblock": "Acute respiratory failure may occur early in the postoperative course, requiring\n      endotracheal intubation and mechanical ventilation in selected patients, thus increasing\n      morbidity and mortality and prolonging intensive care unit (ICU) and hospital stay.We will\n      perform a multicenter, prospective, randomized clinical trial to compare the efficacy of non\n      invasive ventilation (NIV) which associated pressure support ventilation (PSV: 5 to 15\n      cmH2O) and positive end expiratory pressure (PEEP: 5 to 10 cmH2O) with standard oxygen\n      therapy in the treatment of postoperative acute respiratory failure. We also set out to\n      examine the hypothesis that early application of NIV may prevent intubation and mechanical\n      ventilation in patients who develop acute respiratory failure after abdominal surgery."
        }, 
        "brief_title": "Non Invasive Ventilation in Abdominal Postoperative Period", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Surgery", 
            "Trauma to the Abdomen", 
            "Acute Respiratory Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Distress Syndrome, Adult", 
                "Respiratory Insufficiency", 
                "Abdominal Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "The Non-Invasive Ventilation After Surgery (NIVAS) is an investigator-initiated,\n      multi-center, stratified, two-arm parallel-group trial with a computer-generated allocation\n      sequence and electronic system based randomization. The study protocol and statistical\n      analysis plan were approved for all centers by a central Ethics Committee (France) according\n      to French law.The NIVAS study is conducted in accordance with the declaration of Helsinki\n      and was registered on August 2013.All centers have a long experience with NIV (more than 10\n      years of NIV use for ARF, and more than 5 years of NIV use for ARF following abdominal\n      surgery). Randomization will stratified by department, age (less or more 60 years), site of\n      surgery (upper or lower abdominal) and according to the presence or absence of postoperative\n      epidural analgesia as this may influence outcomes. Treatment assignments will concealed from\n      patients, research staff, the statistician, and the data monitoring and safety committee."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Eligibility :\n\n          -  age of more than 18 years\n\n          -  scheduled for elective or not elective abdominal surgery requiring laparotomy or\n             laparoscopy and general anesthesia.\n\n        Inclusion :\n\n          -  acute respiratory failure occurring within the seven days of the surgery procedure\n             which is defined as presence and persistence for at least 30 min and at least one of\n             the two followings: 1) a respiratory rate of more than 30 breaths per minute and 2)\n             clinical signs suggestive of respiratory muscle fatigue, increased work of breathing,\n             or both, such as use of respiratory accessory muscles, paradoxical motion of the\n             abdomen, or retraction of intercostal spaces\n\n          -  hypoxemia defined by a PaO2 lower than 60 mmHg in ambient air or lower than 80 mmHg\n             under 15 liters O2 or an arterial O2 saturation by pulse-oximetry (SpO2) lower than\n             90% (PaO2/FiO2< 200 mmHg).\n\n        Exclusion Criteria:\n\n          -  Emergency procedure surgery (operation that must be performed as soon as possible and\n             no longer than 12 hours after inclusion in the study)\n\n          -  previous recruitment into another trial.\n\n          -  Cardiopulmonary arrest\n\n          -  Glasgow coma scale <8\n\n          -  Absence of airway protective gag reflex\n\n          -  Upper airway obstruction\n\n          -  Pregnancy.\n\n          -  Patients who refuse to undergo endotracheal intubation, whatever the initial\n             therapeutic approach\n\n          -  Chronic home non invasive ventilation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01971892", 
            "org_study_id": "UF 9015"
        }, 
        "intervention": [
            {
                "arm_group_label": "Non invasive ventilation (NIV)", 
                "description": "Non invasive ventilation (NIV) which associated pressure support ventilation (PSV: 5 to 15 cmH2O) and positive end expiratory pressure (PEEP: 5 to 10 cmH2O). NIW will be delivered through a facial mask with either NIV ventilator or ICU ventilator with NIV option", 
                "intervention_name": "Non Invasive ventilation (facial mask and NIV ventilator)", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "standard oxygen therapy with facial mask", 
                "description": "facial Venturi mask", 
                "intervention_name": "Standard oxygen therapy with facial mask", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Abdominal surgery;", 
            "Postoperative complication;", 
            "Acute respiratory failure;", 
            "Hypoxemia;", 
            "Intubation;", 
            "Non-invasive ventilation"
        ], 
        "lastchanged_date": "October 23, 2013", 
        "location": {
            "contact": {
                "email": "s-jaber@chu-montpellier.fr", 
                "last_name": "Samir Jaber, MD PhD", 
                "phone": "+ 33 4 67 33 72 71"
            }, 
            "facility": {
                "address": {
                    "city": "Montpellier", 
                    "country": "France", 
                    "zip": "34000"
                }, 
                "name": "Department of Anesthesiology & Critical Care, St Eloi University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Non Invasive Ventilation After Abdominal Surgery in Postoperative Acute Respiratory Failure: a Multicenter Randomized Controlled Trial.", 
        "overall_contact": {
            "email": "s-jaber@chu-montpellier.fr", 
            "last_name": "Samir Jaber, MD PhD", 
            "phone": "+33 4 67 33 72 71"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Montpellier", 
            "last_name": "Samir Jaber, MD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Endotracheal intubation.", 
            "measure": "The primary end point for the comparison between noninvasive ventilation (NIV) and standard oxygen therapy will be the tracheal intubation within 7 days after the initiation of treatment.", 
            "safety_issue": "Yes", 
            "time_frame": "primary end point will be evaluated within 7 days after the initiation of treatment."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01971892"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Gas exchange will be obtain from arterial blood gases from an arterial line (radial or femoral). Judgement criteria for gas exchange will be oxygenation evaluated by PaO2/FiO2 ratio and PaCO2.", 
                "measure": "Gas exchange after one to two hours after inclusion in the protocol", 
                "safety_issue": "Yes", 
                "time_frame": "one to two hours after inclusion in the protocol"
            }, 
            {
                "description": "Pulmonary infection\nUrinary infection\nCatherter related infection\nBacteriemia and Mortality", 
                "measure": "nosocomial infections within the 14 days and mortality", 
                "safety_issue": "Yes", 
                "time_frame": "At D-14 that means 14 days after initiation of treatment"
            }, 
            {
                "description": "Total ICU stay, i.e, from ICU admission until discharge will be also evaluated at a maximum of 90 days (which is the end of the follow up of the study).", 
                "measure": "length of ICU", 
                "safety_issue": "Yes", 
                "time_frame": "From inclusion until the study until discharge or at 90 days maximal of ICU"
            }
        ], 
        "source": "University Hospital, Montpellier", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Montpellier", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}